For the past ten years, the industry has seen an increased demand to determine fair market value of CRO and other clinical trial service providers.
Clinical Maestro™ is an end-to-end elegant cloud-based platform to more efficiently budget, source and manage complex clinical programs.
We believe that intuitive technology, complete transparency and effective communication between biopharmaceutical companies and providers will revolutionize the productivity of clinical research. Clinical Maestro™ is developed by Strategikon Pharma in San Rafael, California.
For more information, please visit www.clinicalmaestro.com.
Strategikon Pharma announced the latest augmentations of its flagship Clinical Maestro™ platform, which features the Fast Track RFP, an innovative bidding capability for Sponsors to accelerate clinical trial outsourcing and leverages service provider expertise.
Strategikon Pharma has announced the commercial release of its Pharma (Sponsor) Edition SOURCE™ module for automating key processes in clinical outsourcing, as well as its Provider (CRO) Edition CORE™ and LINK™ modules for digital bid costing and third-party sourcing.
Strategikon Advances Planning and Financial Management for Life Sciences with Launch of Clinical Maestro™
New Capabilities Revolutionize Clinical Trial Forecasting, Planning, and Contracting